Galactose medium culturing decreases HCV virion production but has no effect on virus replication and entry. by Tao Yu (176965)

The UL4 mutation alleviated inflammation in PRV-infected mice. by Xiaohua Zhang (350570)

Subjects:

The UL4 mutation alleviates inflammation in PRV-infected pigs. by Xiaohua Zhang (350570)

Subjects:

Fig 12 - by Demiana H. Hanna (11512956)

PRV UL4 augments ASC oligomerization and speck formation. by Xiaohua Zhang (350570)

Subjects:

IMP-1088 decreases infectivity of progeny VACV particles. by Lalita Priyamvada (421536)

CHIKV-infected primary joint tissue fibroblasts display decreased MHC-I cell surface expression. by Brian C. Ware (8544672)

EZH2 inhibitor, GSK343, decreased tri-methylation of Histone 3 at Lysine 27. by Laura V. Bownes (10276762)

“…H3 expression was unchanged. (B, C) Similar to long-term passage cell lines, immunoblotting of the human neuroblastoma PDXs demonstrated a decrease in EZH2 expression with the inhibitor GSK343 as well as a decrease in tri-methylation of Histone 3 at Lysine 27, but H3 was not significantly changed.…”

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>C</b>) LDs, stained with a neutral lipid dye (LipidTOX), are more abundant in pericardial nephrocytes (dashed outlines) of HFD than STD larvae. …”

H1.2 inhibits migration and invasion of A549 cells. by Juan Du (118107)

“…<b>(C–E)</b> Effect of H1.2 on A549 cell migration under normoxic and anoxic conditions according to a Transwell assay. …”

Conditions for UV exposures and UV dose calculations for E. coli K-12 and MS2 disinfection experiments with NOM and PBS, including experiments for photorepair. by Daniel Ma (12698752)

Subjects:

The expression of LDHA, a glycolysis-associated protein, was suppressed by the inhibition of YAP. by Sha Wan (1650814)

Subjects:

TLR2 deficiency decreased TGF-β1 expression, phosphorylated Smad2/3 and myofibroblasts activation induced by <i>C</i>. <i>sinensis</i>. by Yuru Wang (846969)

Subjects:

Intermediate architecture can form despite decreased cell-substrate adhesion. by Christian Cammarota (18284149)

“…<p>A) Cell-substrate connections decrease (A) and cell-cell connections increase (A’) as cell density increases across tested values of cell-substrate adhesion strengths when spreading is scaled nonlinearly in simulations. …”

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

Prorocentin-5: A Cytotoxic Polyketide from the Benthic Marine Dinoflagellate <i>Prorocentrum lima</i> by Yunseok Choi (5625245)

Subjects:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

“…The antiproliferative activity of the novel <i>mono</i>- and <i>bis</i>(dimethylpyrazolyl)-<i>s</i>-triazine derivatives was studied against three cancer cell lines, namely, MCF-7, HCT-116, and HepG2. <i>N</i>-(4-Bromophenyl)-4-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-morpholino-1,3,5-triazin-2-amine <b>4f</b>, <i>N</i>-(4-chlorophenyl)-4,6-bis­(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-1,3,5-triazin-2-amine <b>5c</b>, and 4,6-<i>bis</i>(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-<i>N</i>-(4-methoxyphenyl)-1,3,5-triazin-2-amine <b>5d</b> showed promising activity against these cancer cells: <b>4f</b> [(IC₅₀ = 4.53 ± 0.30 μM (MCF-7); 0.50 ± 0.080 μM (HCT-116); and 3.01 ± 0.49 μM (HepG2)]; <b>5d</b> [(IC₅₀ = 3.66 ± 0.96 μM (HCT-116); and 5.42 ± 0.82 μM (HepG2)]; and <b>5c</b> [(IC₅₀ = 2.29 ± 0.92 μM (MCF-7)]. …”

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

“…The antiproliferative activity of the novel <i>mono</i>- and <i>bis</i>(dimethylpyrazolyl)-<i>s</i>-triazine derivatives was studied against three cancer cell lines, namely, MCF-7, HCT-116, and HepG2. <i>N</i>-(4-Bromophenyl)-4-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-morpholino-1,3,5-triazin-2-amine <b>4f</b>, <i>N</i>-(4-chlorophenyl)-4,6-bis­(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-1,3,5-triazin-2-amine <b>5c</b>, and 4,6-<i>bis</i>(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-<i>N</i>-(4-methoxyphenyl)-1,3,5-triazin-2-amine <b>5d</b> showed promising activity against these cancer cells: <b>4f</b> [(IC₅₀ = 4.53 ± 0.30 μM (MCF-7); 0.50 ± 0.080 μM (HCT-116); and 3.01 ± 0.49 μM (HepG2)]; <b>5d</b> [(IC₅₀ = 3.66 ± 0.96 μM (HCT-116); and 5.42 ± 0.82 μM (HepG2)]; and <b>5c</b> [(IC₅₀ = 2.29 ± 0.92 μM (MCF-7)]. …”

Distribution Coefficients of the REEs, Sr, Y, Ba, Th, and U between α‑HIBA and AG50W-X8 Resin by Haoyu Li (1672648)

“…For all 19 elements, the distribution coefficients decrease with increasing acid concentration. For the REEs, a linear relationship is observed in log–log space between <i>K</i>_d values and α-HIBA molarity. …”